A081105
Randomized Study of Erlotinib vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Principal Investigator(s): Jason W. Suh, MD
Status: Closed to Enrollment, Patients in Follow-Up